NCT02141438 Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer Status COMPLETED Phase N/A
NCT02138825 Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP) Status TERMINATED Phase PHASE2
NCT02138812 Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel Status TERMINATED Phase PHASE1
NCT02135484 Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases Status COMPLETED Phase NA
NCT02123524 Rivaroxaban Anticoagulation for Superficial Vein Thrombosis Status COMPLETED Phase PHASE3
NCT02122913 A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer Status COMPLETED Phase PHASE1
NCT02117791 Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH ) Status COMPLETED Phase N/A
NCT02115542 Single Agent Regorafenib in Refractory Advanced Biliary Cancers Status COMPLETED Phase PHASE2
NCT02114658 Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients Status COMPLETED Phase PHASE2
NCT02111564 A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients Status COMPLETED Phase PHASE3
NCT02106858 Stivarga Regulatory Post-Marketing Surveillance Study in Korea Status COMPLETED Phase N/A
NCT02106845 Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors. Status COMPLETED Phase PHASE1
NCT02106832 Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE) Status COMPLETED Phase PHASE3
NCT02098538 Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma Status COMPLETED Phase PHASE2